OTC Markets EXMKT • USD
Q BioMed Inc. (QBIO)
At close: May 29 at 3:18 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Nov 2021) | Next Qtr. (Feb 2022) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -0.15 | -0.11 | -- | -- |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Nov 2021) | Next Qtr. (Feb 2022) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 105k | 75k | 196k | 284k |
Low Estimate | 1M | 3M | 1.55M | 36M |
High Estimate | 1M | 3M | 1.55M | 36M |
Year Ago Sales | -- | -- | 30k | 196k |
Sales Growth (year/est) | -- | -- | 553.30% | 44.90% |
Earnings History
CURRENCY IN USD | 11/30/2020 | 2/28/2021 | 5/31/2021 | 8/31/2021 |
---|---|---|---|---|
EPS Est. | -0.08 | -0.14 | -0.12 | -0.12 |
EPS Actual | -0.15 | -0.11 | -0.08 | -0.07 |
Difference | -0.07 | 0.03 | 0.04 | 0.05 |
Surprise % | -87.50% | 21.40% | 33.30% | 41.70% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Nov 2021) | Next Qtr. (Feb 2022) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | -0.11 | -0.09 | -0.4 | -0.18 |
30 Days Ago | -0.11 | -0.09 | -0.4 | -0.18 |
60 Days Ago | -0.11 | -0.09 | -0.4 | -0.18 |
90 Days Ago | -0.11 | -0.09 | -0.4 | -0.18 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Nov 2021) | Next Qtr. (Feb 2022) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | QBIO | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 8.30% |
Next Qtr. | -- | -- | -- | 10.70% |
Current Year | -- | -- | -- | 4.90% |
Next Year | -- | -- | -- | 12.50% |
Next 5 Years (per annum) | -- | -- | -- | 11.23% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Downgrade | Roth Capital: Buy to Neutral | 11/29/2018 |
Related Tickers
NMTRQ 9 Meters Biopharma, Inc.
0.0000
0.00%
CFRXQ ContraFect Corporation
0.0150
0.00%
HGENQ Humanigen, Inc.
0.0002
+100.00%
ANIX Anixa Biosciences, Inc.
2.5500
+8.05%
ADXN Addex Therapeutics Ltd
9.00
-1.85%
ARDS Aridis Pharmaceuticals, Inc.
0.0700
-3.31%
THTX Theratechnologies Inc.
1.2200
-0.81%
OK10.F OKYO Pharma Limited
1.3600
0.00%
APTCF Advanced Proteome Therapeutics Corporation
0.0002
-99.46%
APE1.F Addex Therapeutics Ltd
7.25
-7.05%